MATT TINDALL, MBA

Mr. Tindall has extensive leadership experience as a Board Chairman, CEO, Executive and Founder of life sciences companies across multiple therapeutic modalities and domains including, rare disease, cardiovascular disease, neurology, oncology, infectious disease and bioinformatics. Over the past two decades, Mr. Tindall led teams at Fabric Genomics (acquired by GeneDx), IMS Health (now IQVIA), Digitas […]

Cristina Larkin, MBA

Cristina Larkin, MBA has more than 30 years of leadership experience in life science companies, serving as COO, CCO, Board Member, and Advisor from pre-clinical through commercial stages. She has helped raise over $400 million in equity and more than $1 billion in business development and non-dilutive capital. Most recently, Cristina was COO/CCO of Spero […]

Bennett Nemser, PhD

Bennett Nemser, PhD, is Chief Program Officer at the Steven & Alexandra Cohen Foundation, where he oversees the foundation’s health portfolios, including the Cohen Psychedelic Research & Health Initiative and the Cohen Lyme & Tick-Borne Disease Initiative. He holds a PhD in Public Health and an MBA, and has extensive experience with global health systems […]